Theranos Founder’s Partner Unveils New Blood Testing Venture — Indeed, It’s True

Elizabeth Holmes, the infamous ex-leader of Theranos, is presently enduring an 11-year incarceration for deceiving investors with her notorious blood testing enterprise. In a narrative that feels like satire — yet isn’t — her partner, Billy Evans, is now seeking to secure $50 million for his own blood diagnostics venture.

Despite the widespread skepticism online, this account is entirely genuine, as indicated by The New York Times. Evans, who has two children with Holmes and is said to be an heir to a hotel fortune, has founded a company called Haemanthus — named after a blossom commonly referred to as the “blood lily.” The startup professes to signify “the future of diagnostics” with “a fundamentally new approach to health testing.” Sound familiar?

The resemblances to Theranos haven’t escaped attention. Many are puzzled by Evans’ choice to enter the same contentious field that led to Holmes’ federal conviction. As reported by NPR, Evans has already amassed millions — largely from friends, family, and supporters — and intends to start by diagnosing diseases in pets before progressing to human diagnostics.

The internet, as anticipated, reacted with disbelief and dark humor. On Bluesky, users were quick to mock the situation. One individual joked about Holmes being unavailable for the position of Surgeon General, while another quipped that Evans’ startup was a romantic gesture — launching a potentially fraudulent blood testing venture while his partner serves a sentence for exactly that.

Others envisioned Holmes calling from prison with a fresh concept or speculated that she might simply be a “very dainty vampire.” This tale has reached viral status, not merely for its surreal déjà vu, but for its apparent defiance of logic — and yet, here we are.

In a realm already brimming with peculiar headlines, this one still succeeded in astonishment.